tiprankstipranks
Achilles Therapeutics (ACHL)
NASDAQ:ACHL

Achilles Therapeutics (ACHL) Ownership - Who Owns Achilles Therapeutics?

113 Followers

Achilles Therapeutics (ACHL) Ownership Overview

0.00%0.23%52.56%47.22%
0.00%
Insiders
52.56% Other Institutional Investors
47.22% Public Companies and
Individual Investors
The ownership structure of Achilles Therapeutics (ACHL) stock is a mix of institutional, retail and individual investors. Approximately 52.78% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 47.22% is owned by Public Companies and Individual Investors.
The ownership structure of Achilles Therapeutics (ACHL) stock is a mix of institutional, retail and individual investors. Approximately 52.78% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 47.22% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024Sold$1510968

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,208,775Institution2.95%1,099,985
71,927Institution0.18%65,454
21,590Institution0.05%19,647

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
71,927Institution0.18%65,454
21,590Institution0.05%19,647

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Achilles Therapeutics (ACHL)?
According to the latest TipRanks data, approximately 52.56% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 47.22% is held by retail investors.
    What percentage of Achilles Therapeutics (ACHL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 52.56% of Achilles Therapeutics (ACHL) stock is held by institutional investors.
      What percentage of Achilles Therapeutics (ACHL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 47.22% of Achilles Therapeutics (ACHL) stock is held by retail investors.
        Who owns the most shares of Achilles Therapeutics (ACHL)?
        Felix Baker owns the most shares of Achilles Therapeutics (ACHL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis